Vertex Pharmaceuticals Inc. | Key People and Executives
Jeffrey M. Leiden
Chairman, President & Chief Executive Officer
Alan M. Garber
Independent Director
William D. Young
Independent Director
Sangeeta N. Bhatia
Independent Director
Yuchun Lee
Independent Director
Terrence C. Kearney
Independent Director
Margaret G. McGlynn
Independent Director
Elaine S. Ullian
Lead Independent Director
Bruce I. Sachs
Lead Independent Director
Jeffrey M. Leiden
Chairman, President & Chief Executive Officer
Ian Frederick Smith
Chief Operating Officer & Executive Vice President
Thomas Graney
Chief Financial Officer & Senior Vice President
Reshma Kewalramani
Chief Medical Officer & Executive Vice President
David Matthew Altshuler
Chief Scientific Officer & EVP-Global Research
Michael J. Parini
Executive VP, Chief Legal & Administrative Officer
Katharine Jensen
Head-Corporate Social Responsibility
Ludovic Fenaux
Senior VP-International Commercial Operations
Stuart A. Arbuckle
Chief Commercial Officer & Executive VP
Paul M. Silva
SVP, Controller & Principal Accounting Officer
Michael Partridge
Senior Vice President-Investor Relations
Kimberly A. White
Chief Communications Officer & Senior VP
Zachry Barber
Senior Director-Investor Relations
Stephanie Franklin
Chief Human Resources Officer & Senior VP
Michael J. LaCascia
Secretary & Senior Vice President
Amit K. Sachdev
Chief Regulatory Officer & Executive VP
Alan M. Garber
Independent Director
William D. Young
Independent Director
Sangeeta N. Bhatia
Independent Director
Yuchun Lee
Independent Director
Terrence C. Kearney
Independent Director
Margaret G. McGlynn
Independent Director
Elaine S. Ullian
Lead Independent Director
Bruce I. Sachs
Lead Independent Director
| Address |
50 Northern Avenue
Boston Massachusetts 02210
United States
|
|
Employees
|
- |
| Website |
http://www.vrtx.com |
| Updated |
07/08/2019 |
| Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S. |
